lixivaptan has been researched along with urea in 2 studies
| Studies (lixivaptan) | Trials (lixivaptan) | Recent Studies (post-2010) (lixivaptan) | Studies (urea) | Trials (urea) | Recent Studies (post-2010) (urea) |
|---|---|---|---|---|---|
| 80 | 10 | 26 | 45,450 | 2,047 | 9,188 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decaux, G | 1 |
| Couturier, BS; Decaux, G; Gankam Kengne, F; Soupart, A | 1 |
1 trial(s) available for lixivaptan and urea
| Article | Year |
|---|---|
Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Diuresis; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Potassium; Pyrroles; Sodium; Urea; Uric Acid; Water; Water-Electrolyte Balance | 2001 |
1 other study(ies) available for lixivaptan and urea
| Article | Year |
|---|---|
Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Astrocytes; Benzamides; Blood-Brain Barrier; Brain Diseases; Chronic Disease; Demyelinating Diseases; Hyponatremia; Male; Microglia; Pyrroles; Rats; Rats, Wistar; Saline Solution, Hypertonic; Urea | 2015 |